HMGB1 and neoplasm: When HMGB1 is released from dying cells, the activated TLR4/MyD88 pathway enhances INF-β signal transduction [59], stimulates immune activity [60], and up-regulates the expression of PD-L1 in neighboring surviving tumor cells.